MétaCan
Menu
Back to cohort
Record W4413846002 · doi:10.1186/s13063-025-09024-0

SATURN MRI: study protocol for the statin use in intracerebral hemorrhage patients MRI ancillary study

2025· article· en· W4413846002 on OpenAlexaff
Sarah Marchina, Lydia D. Foster, Sharon D. Yeatts, Pooja Khatri, Kimberlee Bernstein, Aaron P. Perlmutter, Elizabeth Heistand, Eric E. Smith, Mike Sharma, Joseph P. Broderick, Vasileios‐Arsenios Lioutas, Joan Martí‐Fábregas, Magdy Selim, Ashkan Shoamanesh

Bibliographic record

VenueTrials · 2025
Typearticle
Languageen
FieldMedicine
TopicIntracerebral and Subarachnoid Hemorrhage Research
Canadian institutionsPopulation Health Research InstituteUniversity of Calgary
FundersNational Institute of Neurological Disorders and Stroke
KeywordsMedicineIntracerebral hemorrhageHyperintensityMagnetic resonance imagingStatinStroke (engine)Internal medicineCardiologyRadiologySubarachnoid hemorrhage

Abstract

fetched live from OpenAlex

BACKGROUND: The benefit-risk of statins in patients with lobar intracerebral hemorrhage (ICH) is under investigation in the StATins Use in intRacerebral hemorrhage patieNts (SATURN) trial. The relationship between statin use in ICH survivors, MRI markers of cerebral small vessel disease (CSVD), and outcomes such as recurrent ICH or major adverse cardiovascular or cerebrovascular events (MACCE) is unclear. The ancillary study, SATURN-MRI, intends to evaluate the interrelationship between statin use, the progression of MRI markers of CSVD, and cognitive and functional outcomes. Additionally, SATURN-MRI aims to assess whether baseline MRI markers of CSVD interact with statin continuation for the outcomes of recurrent ICH or MACCE in patients with lobar ICH. METHODS: A target of 894 SATURN participants will undergo a baseline MRI within 7 days of randomization and a repeat MRI at the end of the 24-month follow-up period. Any SATURN subject without contraindication to MRI has the option to participate in SATURN MRI. MRIs will be reviewed by blinded central raters to assess for the presence and burden of markers of CSVD and their progression. The primary outcome is new cerebral microbleeds and/or sulci with cortical superficial siderosis identified on T2*-weighted (GRE, SWI or SWAN) images between baseline and end-study MRI. Additional outcomes include the progression of white matter hyperintensity and incidence of covert infarcts. DISCUSSION: The results will provide insights about the interrelationship between the effects of statins, progression of MRI markers of CSVD, and functional and cognitive outcomes. They might lead to the validation of MRI markers as tools to assist with individualized decision-making regarding the effects of statins continuation/discontinuation in patients with lobar ICH. TRIAL REGISTRATION: ClinicalTrials.gov NCT03936361. SATURN Trial was originally registered on May 1, 2019 and modified on February 28, 2022.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.019
metaresearch head score (Gemma)0.017
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.081
Threshold uncertainty score0.272

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0190.017
Meta-epidemiology (narrow)0.0030.003
Meta-epidemiology (broad)0.0050.002
Bibliometrics0.0010.002
Science and technology studies0.0030.002
Scholarly communication0.0020.002
Open science0.0020.002
Research integrity0.0030.004
Insufficient payload (model declined to judge)0.0810.025

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.140
GPT teacher head0.458
Teacher spread0.318 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueTrialsSame topicIntracerebral and Subarachnoid Hemorrhage ResearchFrench-language works237,207